
Nucleosyn provides Custom Stable Isotope (2H, 13C, 15N) compounds to support projects dedicated to : Bioanalytics, Omics research, Molecular Imaging, and Biomarker discovery.
[D11]-Capecitabine

Capecitabine is an anticancer drug used to treat breast cancer (advanced or metastatic), gastric cancer (unresectable or metastatic), and colorectal cancer (unresectable or metastatic). It induces serious side effects including blood clotting problems, allergic reactions, and heart problems such as cardiomyopathy and low blood cell counts.
Stable isotope labeled [D11]-Capecitabine is intended for use as an internal standard for the quantification of Capecitabine by LC or GC-mass spectrometry.
C15H11D11FN3O6
M. Briki et al., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2024, 1236, 124039. (read article)
C-J. Wang et al., Adv. Ther., 2021, 38, 9, 4798-4814. (read article)
P. Deng et al., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2015, 989, 71-79. (read article)
M-J. Deenen et al., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 913-914, 30-40. (read article)